Master Alliance Provisions Guide (MAPGuide)

MPP – Afrigen Biologics, RSV mRNA-Based Vaccine, Grant Agreement

  • Term & termination | Term of agreement

11. Term and Termination

11.1. Term. The term of this Agreement commences on 01 December 2023 and continues until the completion of all activities of the Project and the acceptance by MPP of all Reports, unless earlier terminated in accordance with this Section 11.